Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.9753 per EA under NDC 62559066090. Its NADAC has been published 393 times since Feb 13, 2019.
FDA first approved this application on Sep 5, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB
Candesartan Cilexetil and HydrochlorothiazideStrength
16; 12.5 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559066090
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021093FDA Approved
9/5/2000
TE Code
AB
On Market Since
9/26/2018
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has been published 393 times since Feb 13, 2019, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9753 per EA |
|---|---|
| All-time high | $3.4335 (Jun 10, 2020) |
| All-time low | $0.6502 (Nov 20, 2024) |
| 52-week high | $1.0596 |
| 52-week low | $0.7758 |
| Median price | $1.4035 |
| Average price | $1.6447 |
| Largest weekly change | +54.4% (Sep 18, 2024) |
| Weeks tracked | 393 |
| Tracking since | Feb 13, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB, manufactured by ANI Pharmaceuticals, Inc., is $0.9753 per EA (NDC 62559066090), effective Aug 19, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has declined 67.6%. It has been tracked across 393 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
Since Feb 13, 2019, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB has ranged from a low of $0.6502 (Nov 20, 2024) to a high of $3.4335 (Jun 10, 2020), with a median of $1.4035 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 16-12.5 MG TB (NDC 62559066090) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.